Filed under: Technology Dividend Yield : 14.2% Market Cap: $850 million You would never expect a small-cap biotech firm to have a monster dividend yield, but PDL Biopharma ( PDLI ) is a delightful exception. The company engages in the management of “antibody humanization patents,” as well as royalty assets and license agreements with various biotechnology and pharmaceutical firms. In a nutshell, the process of “humanization” helps makes medications compatible with the biology of men and women so that they work properly.

Read the original post:
BloggingStocks